MDM2 and glioblastoma: Recently, Ikliptikawati et al. identified the genomic amplification of NUP107, a core component of the NPC, in glioblastoma (GBM), revealing its overexpression alongside MDM2, a critical E3 ligase responsible for p53 degradation [67].